CARA THERAPEUTICS INC

NetDania - New 12 months Low: CARA THERAPEUTICS INC. - COMMON STOCK

21 11 2023 14:28:41 提供 NetDania Notify

NetDania - New 12 months Low: CARA THERAPEUTICS INC. - COMMON STOCK

14 11 2023 11:06:15 提供 NetDania Notify

Cara Therapeutics Reports Third Quarter 2023 Financial Results

13 11 2023 16:01:00 提供 Nasdaq GlobeNewswire

Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty

02 11 2023 07:00:45 提供 Nasdaq GlobeNewswire

Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023

23 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients

25 9 2023 07:00:32 提供 Nasdaq GlobeNewswire

Cara Therapeutics Reports Second Quarter 2023 Financial Results

07 8 2023 16:01:00 提供 Nasdaq GlobeNewswire

Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors

03 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

02 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

Cara Therapeutics to Present at the Jefferies Healthcare Conference

01 6 2023 07:00:00 提供 Nasdaq GlobeNewswire

Kapruvia® (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

18 5 2023 02:00:00 提供 Nasdaq GlobeNewswire

Cara Therapeutics Reports First Quarter 2023 Financial Results

15 5 2023 16:01:00 提供 Nasdaq GlobeNewswire

Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023

01 5 2023 07:00:01 提供 Nasdaq GlobeNewswire

Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference

10 4 2023 07:00:00 提供 Nasdaq GlobeNewswire

Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report

14 3 2023 07:00:00 提供 Nasdaq GlobeNewswire

Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results

06 3 2023 16:01:00 提供 Nasdaq GlobeNewswire

Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

21 2 2023 07:00:02 提供 Nasdaq GlobeNewswire

Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine

08 2 2023 17:00:00 提供 Nasdaq GlobeNewswire

Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023

17 1 2023 07:00:00 提供 Nasdaq GlobeNewswire

Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference

03 1 2023 07:00:01 提供 Nasdaq GlobeNewswire